Back to News
Market Impact: 0.2

Constellation Brands, Inc. to Report Q1 Financial Results on July 1, 2025

STZBRK.BMSFMRCWISVANGWMGMUFGBCSPIPRTFCRYNDAQ
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsAnalyst EstimatesAnalyst InsightsInsider TransactionsInvestor Sentiment & Positioning
Constellation Brands, Inc. to Report Q1 Financial Results on July 1, 2025

Constellation Brands (STZ) will release Q1 2025 financial results on July 1st after market close, followed by a conference call on July 2nd at 10:30 a.m. ET, where CEO Bill Newlands and CFO Garth Hankinson will discuss performance and outlook. Recent trading activity shows mixed sentiment, with Berkshire Hathaway significantly increasing its stake while Morgan Stanley reduced its position; analysts have issued buy ratings with a median price target of $210.

Analysis

Constellation Brands (STZ) is scheduled to release its Q1 2025 financial results on July 1, 2025, followed by a conference call with CEO Bill Newlands and CFO Garth Hankinson on July 2. The company highlights its status as one of the fastest-growing large CPG companies in the U.S., setting expectations for continued robust performance. Institutional investor activity in STZ reflects a divergence in sentiment: Berkshire Hathaway significantly increased its stake by 113.5% (6,384,676 shares valued at approximately $1.17 billion) in Q1 2025, and FMR LLC also made a substantial addition of 206.4% (3,387,870 shares). Conversely, Morgan Stanley reduced its position by 58.9% (4,741,716 shares), and overall, 926 institutional investors decreased their holdings compared to 484 adding shares in the most recent quarter. Congressional trading data over the past six months shows a net selling inclination, with four sales (totaling up to $130,000) versus one purchase (up to $15,000). Similarly, insider transactions in the last six months included one sale by an EVP of 3,150 shares (estimated $593,901) and one purchase by another insider of 1,000 shares (estimated $186,390), indicating net selling by value. Analyst sentiment remains positive, with three firms issuing buy-equivalent ratings recently (Barclays, Needham, Piper Sandler) and a median price target of $210.00 from four analysts in the last six months, though targets range from $202.00 (Morgan Stanley) to $289.00 (RBC Capital). The press release detailing the earnings date did not provide specific financial expectations, which introduces a degree of uncertainty pending the actual results.